DVHGF
Price
$0.14
Change
-$0.03 (-17.65%)
Updated
Feb 24 closing price
Capitalization
21.31M
HMTXF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Apr 4 closing price
Capitalization
9.87M
Ad is loading...

DVHGF vs HMTXF

Header iconDVHGF vs HMTXF Comparison
Open Charts DVHGF vs HMTXFBanner chart's image
Devonian Health Group
Price$0.14
Change-$0.03 (-17.65%)
Volume$4K
Capitalization21.31M
Hemostemix
Price$0.07
Change-$0.00 (-0.00%)
Volume$3K
Capitalization9.87M
DVHGF vs HMTXF Comparison Chart
Loading...
View a ticker or compare two or three
VS
DVHGF vs. HMTXF commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVHGF is a Hold and HMTXF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (DVHGF: $0.14 vs. HMTXF: $0.07)
Brand notoriety: DVHGF and HMTXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DVHGF: 134% vs. HMTXF: 10%
Market capitalization -- DVHGF: $21.31M vs. HMTXF: $9.87M
DVHGF [@Biotechnology] is valued at $21.31M. HMTXF’s [@Biotechnology] market capitalization is $9.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVHGF’s FA Score shows that 0 FA rating(s) are green whileHMTXF’s FA Score has 1 green FA rating(s).

  • DVHGF’s FA Score: 0 green, 5 red.
  • HMTXF’s FA Score: 1 green, 4 red.
According to our system of comparison, DVHGF is a better buy in the long-term than HMTXF.

Price Growth

DVHGF (@Biotechnology) experienced а 0.00% price change this week, while HMTXF (@Biotechnology) price change was +30.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.88%. For the same industry, the average monthly price growth was -20.27%, and the average quarterly price growth was -19.68%.

Industries' Descriptions

@Biotechnology (-9.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
DVHGF($21.3M) has a higher market cap than HMTXF($9.87M). DVHGF YTD gains are higher at: 8.491 vs. HMTXF (-4.629). DVHGF has higher annual earnings (EBITDA): 140K vs. HMTXF (-1.96M). DVHGF has more cash in the bank: 12.5M vs. HMTXF (63.3K). DVHGF has less debt than HMTXF: DVHGF (2.27M) vs HMTXF (4.77M). DVHGF has higher revenues than HMTXF: DVHGF (22.4M) vs HMTXF (0).
DVHGFHMTXFDVHGF / HMTXF
Capitalization21.3M9.87M216%
EBITDA140K-1.96M-7%
Gain YTD8.491-4.629-183%
P/E RatioN/AN/A-
Revenue22.4M0-
Total Cash12.5M63.3K19,747%
Total Debt2.27M4.77M48%
FUNDAMENTALS RATINGS
HMTXF: Fundamental Ratings
HMTXF
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FHCIX57.95N/A
N/A
Fidelity Advisor Health Care I
BSCAX14.13N/A
N/A
Brandes Small Cap Value A
FTVNX29.81N/A
N/A
FullerThaler Behav Md-Cp Val Investor
PMFMX19.05-0.21
-1.09%
Principal MidCap S&P 400 Index R3
VGTSX18.04-0.48
-2.59%
Vanguard Total Intl Stock Index Inv

DVHGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVHGF has been loosely correlated with CSPHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DVHGF jumps, then CSPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVHGF
1D Price
Change %
DVHGF100%
N/A
CSPHF - DVHGF
38%
Loosely correlated
N/A
WINT - DVHGF
38%
Loosely correlated
-7.69%
JAGX - DVHGF
27%
Poorly correlated
+9.61%
RNAZ - DVHGF
25%
Poorly correlated
-2.88%
HMTXF - DVHGF
21%
Poorly correlated
N/A
More

HMTXF and

Correlation & Price change

A.I.dvisor tells us that HMTXF and DMAC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HMTXF and DMAC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HMTXF
1D Price
Change %
HMTXF100%
N/A
DMAC - HMTXF
22%
Poorly correlated
-0.57%
BIVI - HMTXF
21%
Poorly correlated
+3.17%
AGEN - HMTXF
21%
Poorly correlated
+17.95%
DVHGF - HMTXF
21%
Poorly correlated
N/A
FDMT - HMTXF
12%
Poorly correlated
-4.33%
More